“Chapter 2 Research Ethics and Canadian Nursing: An Evolving Landscape” in “Toward a Moral Horizon”
CHAPTER 2
Research Ethics and Canadian Nursing: An Evolving Landscape1
Janet L. Storch and Brenda Sawatzky-Girling
“Research is a step into the unknown. Because it seeks to understand something not yet revealed, research often entails risks to participants and others. These risks can be trivial or profound, physical or psychological, individual or social. History offers unfortunate examples where research participants have been needlessly, and at times profoundly, harmed by research, sometimes even dying as a result. Ethical principles and guidelines play an important role in advancing the pursuit of knowledge while protecting and respecting research participants in order to try to prevent such occurrences.” (Canadian Institutes of Health Research et al., 2022, p. 5)
IT MAY BE SURPRISING TO SOME that the central ethical principles accepted in health care practice and health care research were developed in response to reports of “research” ethics abuses. As these research abuses came to light, physicians and philosophers in the United States issued the Belmont Report in 1978, which was then published in the Federal Register in 1979. The report identified three basic principles for research with people: respect for persons, beneficence, and justice. These principles were enhanced, used in codes of ethics and other documents, and practiced in evaluating procedures in clinical settings and research environments. They continue to be key to ethical research today.
In this chapter, we will first discuss some of the major research ethics abuses in Europe, the United States and Canada. We pay special attention to those abuses that involved compliant nurses and also played a prominent role in subsequent measures adopted to eliminate or reduce harms in the name of research. We then turn to the development of codes of ethics and processes (in particular Research Ethics Boards, called REBs). We focus on Canadian provisions for guidance, including the development of the Tri-Agency funding body, the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPs 2) guidelines for research, and an explanation of how REBs function. Throughout, the place of nurses in these developments will be examined.
In the latter part of this chapter we use Ethics in Practice case studies to explore the four main roles that advanced practice nurses have related to research ethics: in practice; as managers and leaders; as researchers and research coordinators; and as REB members. We close the chapter by offering areas for research ethics on the moral horizon and reminding nurses why vigilance and leadership must be ongoing when it comes to research ethics.
The Mid-Twentieth Century: A Dubious Era in Medical Research
We begin with a discussion of historical studies that sounded the alarm regarding scientists and health care practitioners who failed to honour the intrinsic value of human beings and respect for human dignity (Canadian Institutes of Health Research et al., 2022). Ours is not an exhaustive review of known atrocities, and certainly others remain untold.
Serious Research Abuses During World War II and in the United States
When the world became aware of the serious human rights abuses inflicted during World War II—including human experimentation—people were shaken. Two of the principal partners in the Axis alliance, Nazi Germany and Imperial Japan, conducted involuntary, inhumane experiments on prisoners of war and so-called “undesirables” and “enemies of the state” for reasons that included determining potential outcomes for their military (Emanuel et al., 2008; Harvard Law School Library, 2020; Tsuchiya, 2008; Weindling, 2008). For example, in one German experiment, researchers sought to determine how long a war pilot might live when shot down over the English Channel, based upon how long prisoners could survive in icy cold water. These trials eventually became known as the infamous “cold experiments in Dachau.” Dr. Josef Mengele and Dr. Sigmund Rascher were the German physicians viewed as responsible for this horrific research (Seidelman, 1988). Investigators in similar projects studied the effect of exposing prisoners to exotic diseases and phosgene gas, a biological warfare agent, to determine how humans might respond, and then to develop remedies to protect future soldiers (Luna & Macklin, 2009). Scholars like Copeland (2021) and Shields and Benedict (2014)—and victims like Eva Mozes Kor (Mozes Kor & Wright, 1995), one of “Dr. Mengele’s Twins”—describe the roles that nurses and midwives willingly (and unwillingly) played in the Nazi medical experiments.
Despite the powerful condemnation of Nazi medicine and medical research at the Nuremberg trials (1946–47), experimentation on humans persisted and even increased after World War II in Western industrialized nations (Beecher, 1966; Mosby, 2013). Researchers typically enrolled healthy people from populations made vulnerable by their circumstances. Such circumstances included people from government institutions such as prisons, military camps, and homes for people with disabilities. In addition, investigators used medical students and family members (Lederer, 1995). Other experiments in the United States that caught the attention of the world include
1. the initial launch and subsequent continuation of the Tuskegee Syphilis Study (1932–1972),
2. the Willowbrook State School hepatitis studies (1950–1970),
3. the Salk polio vaccine testing at Polk State School and Watson’s Crippled Children’s Home (1950s), and
4. the harvesting and use of Henrietta Lacks’s unique “HeLa” cells (1951 to present).
Nurses had a role in all of these experiments. These nurses may have been somewhat aware that research activities were being conducted without the subjects’ full knowledge. For example, in 1932, the United States Public Health Service launched a study designed to determine the natural history of untreated syphilis in Black populations. Initially titled the “Tuskegee Study of Untreated Syphilis in the Negro Male,” what is now commonly referred to as the Tuskegee Syphilis Study began when there was no known treatment for syphilis. Researchers and support staff recruited 600 Black men from a poor community in Alabama (Dunn & Chadwick, 2004; Jones, 2008). The study was technically well designed, with a treatment group of men who had syphilis and a control group of men who did not have the disease. A local Black nurse named Eunice Rivers, who had trained at the Tuskegee Institute’s School of Nursing, was hired to be the on-site representative (Dunn & Chadwick, 2004). The start of study predated the discovery of penicillin; thus, since at the time there was no known treatment for syphilis, the men were all given only check-ups and aspirin by physicians and public health nurses. But when penicillin was discovered as a cure for syphilis in 1942, most subjects were actively denied penicillin, and the devastating effects of untreated syphilis continued to be observed. The study was only stopped in 1972 after an article in the New York Times (Heller, 1972) prompted widespread public outrage.
Nurses also took part in the Willowbrook State School experiment, conducted in New York between 1950 and 1970, which studied the effects of the hepatitis virus on children with developmental disabilities. After 1964, researchers deliberately infected children with hepatitis as a requirement of admission to the institution (Robinson & Unruh, 2008). Similarly, in the 1950s, Jonas Salk used children from the Polk State School and the Watson Home for Crippled Children (in addition to himself and his family) as research subjects to study the effects of his polio vaccine (Juskewitch et al., 2010; Meldrum, 2008). Nurses participated in these studies too, or at least would have been involved in caring for the children and witnessing the effects of the trials.
Finally, we briefly outline the case of a Black woman named Henrietta Lacks, who became unwittingly famous for her rare and immortal “HeLa” cell line. In 1951, at 31 years of age, Lacks was diagnosed with aggressive cervical cancer which required regular gynecological check-ups (Skloot, 2010). Unbeknownst to Lacks, the visits were not just for her clinical care; they were also for research. The nurses involved in Lacks’s visits would have known that the “check-ups” she was required to attend were, in fact, to regularly obtain cells from her cervix, named after her as “HeLa” cells. Consent for the research purposes was not obtained, as was the norm at the time. “HeLa” cells have become a billion-dollar industry and are still widely used to study the effects of toxins, drugs, hormones, viruses, and gene mapping. Yet for many years, Lacks remained virtually unknown, and her family was impoverished; they could not afford health insurance (Skloot, 2010). In 2021, the estate of Henrietta Lacks sued a biotechnology company, accusing the company of continuing to profit from cells that physicians at Johns Hopkins Hospital took in 1951 without Lacks’s knowledge or consent (Associated Press, 2021).
Selected Serious Research Abuses in Canada
Canada’s history also includes ethically dubious medical research during the mid-twentieth century. Particularly egregious instances include
•nutritional studies in Indigenous communities and residential schools (1942–1952),
• lysergic acid diethylamide (LSD) studies at Allan Memorial Institute and Kingston Prison for Women (1950s),
• anaesthetic testing on a university student at the University of Saskatchewan (1961), and
• genetic testing on blood samples from members of the Nuu-chah-nulth First Nation (1982–2008).
Between 1942 and 1952, some of Canada’s leading nutrition experts conducted nutritional studies in Indigenous communities and in the residential school system. In 2013, historian Ian Mosby exposed that one of the most ambitious studies, performed by Canada’s Department of Indian Affairs, was conducted as the “James Bay Survey of the Attawapiskat and Rupert’s House Cree First Nations.” In these studies, researchers denied control and treatment groups of already malnourished children adequate nutrition. Nurses were instrumental in implementing the study procedures. To control as many factors as possible, these procedures continued, even though they were known to harm the children. For example, even previously available dental care was denied in some settings because the researchers wanted to observe the state of dental caries and gingivitis with malnutrition. Parents were not informed, nor were consents obtained. Even after children died, the experiments continued. MacDonald et al. (2014) titled their paper on the topic “Canada’s shameful history of nutrition research.” An interviewer from the Canadian Broadcasting Corporation’s (CBC) Unreserved program spoke to Ian Mosby in April 2021 in the episode “The dark history of Canada’s Food Guide: How experiments on Indigenous children shaped nutrition policy” (Tennant, 2021).
During the 1950s to the 1960s, experiments investigating the psychedelic drug LSD as a potential cure for mental illness were conducted in various locations across Canada. The most famous of these, Project MKULTRA, was led by Dr. Ewen Cameron, a prominent psychiatrist affiliated with the Allan Memorial Institute in Montreal, who had been called upon to assess the fitness of Nazi war criminals to stand trial at Nuremberg (Collins, 1997; Lemov, 2011). Cameron began to employ harmful techniques on his patients without their realization that they were being experimented on. The procedures included shock therapy, supplemented by large doses of LSD, and putting patients into insulin or drug-induced comas for weeks, during which they were subjected to taped messages for 16 hours per day. Cameron’s patients suffered significant, ongoing harm as a result of these procedures. Some of these former patients successfully sued the United States Central Intelligence Agency, while other patients sued the Canadian government; both were funders of Cameron’s projects. The CBC program The Fifth Estate followed this story for many years (Cashore & Smart, 2017).
At the Kingston Prison for Women in the early 1960s, 23 inmates were involuntary research subjects in a study of the psychotherapeutic use of LSD. This practice was reported to Correctional Services Canada in 1965; the report, however, led to further investigations on the use of LSD and shock therapy (Gilmore et al., 1998).
In 1961, Walter Halushka, a 21-year-old student at the University of Saskatchewan, agreed to be a subject to test a new anaesthetic called Fluoromar at the University Hospital. Halushka was told that the test would last a couple of hours and that it was “perfectly safe.” In fact, the researchers had never administered the anesthetic before. Halushka and one witness signed a form titled “Consent for Tests on Volunteers” (Veatch, 1977). Normally, operating room nurses would review the consent form with a patient; there was no specific mention of such a process in the court testimony. The form Halushka signed was inadequate, given that the standard in 1961 required that research subjects understand the procedure and its risks. Unfortunately, none of the nurses questioned the two doctors or requested more information about the procedure (at the time, nurses questioning doctors was not the practice). Halushka appeared for the test, the anaesthetic was administered, and shortly thereafter he suffered a cardiac arrest. He was resuscitated, but remained unconscious for four days. Halushka was discharged from the hospital after 10 days, having been paid $50 for the test. The procedure inflicted brain damage that prevented him from continuing his university studies.
In the landmark case of Halushka v. University of Saskatchewan (1965), Walter Halushka sued the hospital and the two physicians and was awarded $22,500. Justice Hall ruled that
the consent given by a patient to a physician or surgeon, to be effective, must be an ‘informed’ consent freely given.… The subject of medical experimentation is entitled to a full and frank disclosure of all the facts, probabilities and opinions which a reasonable man might be expected to consider before giving his consent. (Veatch, 1977, pp. 291–293)
The examples of research ethics abuse described thus far are commonly cited as having established the standard for consent to research today.
Another well-known breach of research ethics in Canada occurred from 1982–1995. During those years, Nuu-chah-nulth First Nation provided a UBC researcher with blood samples for genetic testing to study the high incidence of rheumatic disease, an area of concern in their community. The study team included physicians and medical students as well as nurses. Years later, the community learned that the researcher had relocated to universities in two different countries and had taken the specimens with him. In fact, the researcher had gone on to conduct diverse research that was not part of the original consent, including biological anthropology research that the Indigenous community perceived as particularly harmful. In response, the Nuu-chah-nulth Tribal Council Research Ethics Committee (2008) developed research protocols that were responsive to the context of their unique communities. The remaining blood samples were eventually returned to British Columbia in 2004, and destroyed in 2008 (Arbour & Cook, 2006; Ha-Shilth-Sa, 2013; Wiwchar, 2004).
Responses to Research Ethics Abuses
In response to ongoing revelations about ethics abuses in the name of research, in this section we review the key ways in which the Euro-Western world responded with codes of ethics, REBs, and ethics organizations. These structures were designed to meet three ethical objectives: promoting socially beneficial research, respecting the dignity and rights of research participants, and maintaining trust between the research community and society as a whole (McDonald, 2000).
Codes of Ethics
Before the 1950s, researchers engaged in human experimentation relied on informal guidelines or professional codes of ethics (Halpern, 2004). These ethical guidelines and codes were rooted in a worldview that reflected (and continues to reflect) the dominant traditions of Euro-Western moral philosophy, cultural and methodological perspectives, and political and social theory (Hayward et al., 2021, p. 403). Early work on such codes included the Berlin Code, prepared in 1900. The initial response by medical observers to World War II research abuses, particularly the Nazi Medical Experiments, was to establish some rules for research through the use of codes of ethics. The Nuremberg “Doctors’ Trial” in 1946–1947, the subsequent Nuremberg Code (1949), and the World Medical Association’s Declaration of Helsinki (1964) laid the fundamentals of biomedical ethics with regulations and requirements for ethical procedures. Thus, ethical standards of informed consent have been in place since World War II. Medical practitioners and researchers have used these codes as important guides for practice and research, yet as noted, at times they have been ignored.
The most influential of these documents was the Belmont Report (National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979). The Belmont Report, seen as the cornerstone of modern health care ethics (including research), outlines a set of core ethical principles: respect for persons, beneficence, and justice. The principles were promoted in the release of the 1979 text titled Principles of Biomedical Ethics, by Tom L. Beauchamp and James F. Childress (2019). The wide use of these three to four principles (the Beauchamp and Childress text includes a fourth principle, nonmaleficence) advanced the moral theory that has become known as principlism.
Research Ethics Boards
Starting in the 1960s, government agencies in industrialized nations took on a greater role in funding medical research. A review process was set up as the main mechanism to provide ethical oversight of research involving humans in accordance with established standards and requirements. Referred to in Canada as Research Ethics Boards (REBs) (and elsewhere as Institutional Review Boards [IRBs], Research Ethics Committees [RECs], etc.), the main responsibility of REBs is to protect the rights and welfare of human research participants by ensuring that studies are conducted in a safe, ethical, and socially responsible way.
Typically, REBs are established by institutions such as universities, hospitals, and other health care facilities to review and approve applications related to research involving human participants. REBs have the power to propose changes, to refuse, and to stop experiments that fall short of ethical requirements. A secondary role for institutional REBs is to protect the interests of the institution and researchers (Stark, 2011). Independent REBs provide ethical review for researchers conducting research projects outside the auspices of an institution. The REB structure is a crucial mechanism to ensure research participant safety and successful research that benefits patients and their families, health care providers, and communities.
Ethics Organizations
Developments in research ethics during the 1960s and 1970s also prompted the founding of a number of ethics centres, including The Hastings Center near New York in 1969, The Kennedy Institute of Ethics at Georgetown University in Washington DC in 1971, and other centres in the US. In Canada, ethics centres and groupings formed in Montreal, Toronto, Halifax, Winnipeg, Edmonton, and Vancouver.
Research Ethics Structures and Guidance in Canada
In this section, we summarize Canada’s unique system of research ethics. This includes the Tri-Agency research funding infrastructure: Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Social Sciences and Humanities Research Council of Canada (SSHRC). In addition, we review the Interagency Advisory Panel on Research Ethics; the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPs 2), Canada’s standard for ethical research; and the structure of REBs.
The Tri-Agency Funding Infrastructure
An ideal system of research ethics takes a holistic “lifecycle approach” that acknowledges the range of ethical issues that exist, or may develop, throughout the complete cycle of scientific knowledge—from creation to translation (Anderson et al., 2011). Over time, the Government of Canada streamlined the research funding process by creating three federal granting councils: CIHR, NSERC, and SSHRC. Collectively, these councils are referred to as the Tri-Agency. They are the major sources of research funding for Canadian post-secondary institutions:
• CIHR funds research primarily intended to improve or have an impact on health, produce more effective health services and products, and strengthen the Canadian health care system (founded in 2000);
• NSERC funds research primarily intended to advance knowledge in the natural sciences and engineering (founded in 1978); and
• SSHRC funds research intended to add to our understanding and knowledge of individuals, groups and societies (founded in 1977).
Nurses mainly apply for funding through CIHR or SSHRC.
To address the need for common research endeavors, in 2001 the Government of Canada also created the Interagency Advisory Panel on Research Ethics (PRE or the Panel) (Panel on Research Ethics, 2023a). This Panel was specifically developed to manage the ethics policy of the funding agencies and to steward the evolution and interpretation of the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPs), the joint research ethics policy statement of CIHR, NSERC, and SSHRC, first published in 1988. Institutions eligible to administer and receive Tri-Agency research funding must agree to adhere to the TCPs as a condition of funding.
Canada’s Standard for Ethical Research: Tri-Council Policy Statement (TCPs 2)
The Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, commonly known as TCPs 2 (Canadian Institutes of Health Research et al., 2022), is the prevailing Canadian standard for ethical research involving humans. Respect for human dignity, the underlying value of the TCPs 2, is expressed through the following three core principles:
• respect for persons: recognizing “the intrinsic value of human beings and the respect and consideration that they are due. It incorporates the dual moral obligations to respect autonomy and to protect those with developing, impaired, or diminished autonomy” (Canadian Institutes of Health Research et al., 2022, p. 277).
• concern for welfare: requiring “researchers and REBs should aim to protect the welfare of participants, and, in some circumstances, to promote that welfare in view of any foreseeable risks associated with the research” (Canadian Institutes of Health Research et al., 2022, p. 8).
• justice: referring “to the obligation to treat people fairly and equitably. Fairness entails treating all people with equal respect and concern. Equity requires distributing the benefits and burdens of research participation in such a way that no segment of the population is unduly burdened by the harms of research or denied the benefits of the knowledge generated from it” (Canadian Institutes of Health Research et al., 2022, p. 272).
Institutions and REBs across Canada have adopted the TCPs 2 even if they do not receive Tri-Agency funding. Those who devised the original TCPs in 1988, as well as ongoing additions to it (2010, 2014, 2018, 2022), fully recognize that the TCPs 2 works in conjunction with other sources of guidance for research ethics, including professional bodies such as the Canadian Nurses Association (CNA) and the Canadian Medical Association. For example, the CNA developed specific research ethics guidelines for nurse researchers in French and English (1994, 2002), where they emphasized the need for extra care and attention when health care professionals are involved with human research. Now, all these different professional organizations’ guidelines have become part of the Tri-Council governance. In addition, the CNA Code of Ethics for Registered Nurses (2017), articulates the following research-related responsibilities as a part of providing safe, compassionate, competent, and ethical care:
10. Nurses support, use and engage in research and other activities that promote safe, competent, compassionate and ethical care, and they use guidelines for ethical research that are in keeping with nursing values.
11. Nurses who are involved in research respect the well-being of persons receiving care above all other objectives, including the search for knowledge. They pay attention to the safety of persons receiving care and to informed consent, the risk-benefit balance, the privacy and confidentiality of data and the monitoring of research. (p. 9, emphasis in original)
Relevant Ethical Guidelines, Policies and Legislation
In Canada, research is governed primarily by ethical guidelines which do not have the force of law; this is unlike the legislative approach taken by some other countries, such as the United States and France. Researchers should apply the guidelines of the TCPs 2 in conjunction with relevant and applicable ethical guidelines, policies, legislation, and regulation. For example, research participants’ rights to privacy are legally protected by federal law (see Personal Information Protection and Electronic Documents Act, 2000) and provincial/territorial laws (see for example BC’s Personal Information Protection Act, 2003). Thus, researchers have the obligation to safeguard any information collected in the context of their study, to know what legislation is applicable, and to comply with it. Legal requirements related to consent and the decision-making capacity of participants are established at the provincial/territorial level, such as BC’s Health Care (Consent) and Care Facility (Admission) Act (1996). Another example applies to clinical trials research regulated under Health Canada’s Food and Drugs Act (1985). In addition, depending on the type of research and the source of funding, Canadian researchers can be subject to international ethical guidance such as the International Conference on Harmonisation Good Clinical Practice Guidelines (ICH-GCP) (n.d.) and foreign oversight bodies such as the United States Food and Drug Administration.
TCPs 2: A Living Document
Another important feature of TCPS 2 is that the policy is positioned as a “living document” and continues to be revised as new challenges are placed before REBs, researchers, and our society. Processes are in place to engage with Canada’s research community, to communicate interpretations of the TCPs 2, and to develop new guidance. For example, a very significant addition to the TCPs was realized in 2010 with a new chapter, “Research Involving the First Nations, Inuit and Métis Peoples of Canada” (Canadian Institutes of Health Research et al., 2022, pp. 146–182). This new Chapter 9 reflected a growing awareness about the need to conduct and review research involving Indigenous people more respectfully, and with understanding of a community’s unique cultural traditions, customs, codes of practice, and worldview. Shawn Wilson (2008) describes research done “in a good way” as a sacred endeavour, grounded in respect and traditional wisdom, which leads to the support of community and creation of healing. The inclusion of Chapter 9 moves toward a “two-eyed seeing approach” (Bartlett et al., 2012; Bull, 2016) that incorporates both broad Indigenous principles (such as relational accountability, communality of knowledge, reciprocity, and benefit sharing [Kara, 2018; Wilson, 2008]) and core Western ethical principles (respect for persons, concern for welfare, and justice). In addition, TCPs 2’s Chapter 9 is intended to work with Indigenous-led ethical processes and protocols such as the First Nations Principles of OCAP (ownership, control, access, and possession) (First Nations Information Governance Centre, n.d.). Researchers can use the OCAP framework for guidance on how First Nations data should be collected, protected, used, or shared in a way that is beneficial and respectful to Indigenous communities. The release of the Truth and Reconciliation Commission of Canada’s final report (2015) reinforces the ongoing need for nurses to understand this new era of Indigenous research ethics.
Also in 2010, the term “participant” replaced “subject” in the TCPs to reflect an ideological departure from framing people as objects of study. In TCPS 2 (2022), participants in research are defined as “those individuals whose data, biological materials, or responses to interventions, stimuli, or questions by the researcher, are relevant to answering the research question(s)” (Article 2.1, p. 14). In 2018, new guidance included how to assess, manage, and review risks to communities, including situations where non-participants might be inadvertently exposed to a research intervention. TCPS 2 updates in 2022 include guidance on broad consent for the storage of data and human biological materials for future unspecified research, streamlining multi-jurisdictional research ethics review of minimal risk research, and research involving totipotent stem cells and human cell lines. The ongoing input of nurse researchers to the TCPs guidelines is essential in response to societal, policy, and legislative changes, and related ethical challenges, and as new approaches of nursing inquiry are developed.
Research Ethics Education
The Panel organizes education in research ethics for the research community, such as the online tutorial TCPS 2: CORE-2022 (Course on Research Ethics) (Panel on Research Ethics, 2023b). The CORE-2022 applies to all research involving human participants, regardless of discipline or methodology, with a focus on the Canadian context. Prior to research ethics approval, most REBs require that researchers who engage in research with human participants (and their personal information) complete this tutorial. Upon successful completion, learners can obtain a CORE-2022 Certificate of Completion. We recommend that all readers who have not already done so take the time to explore this interesting four-hour course, available at no charge in English and French.
The Panel has also developed educational resources to assist people who are participating in research or are considering joining a study. These resources cover basic information about participation in research, specific information on topics such as privacy, risks and benefits, and consent, and how the ethics guidance in the TCPS 2 aims to provide protection for research participants. We encourage all readers to find opportunities to participate in research studies to gain valuable experience about what it is like to be a study participant.
Canada’s Research Ethics Boards
At the local level, the main body responsible for using the TCPS 2 are researchers, and to oversee their steadfastness there are REBs. The TCPS 2 sets out the following requirements for REB membership:
First, there must be at least five members, including both men and women, of whom at least
a. two members have expertise in relevant research disciplines, fields, and methodologies covered by the REB;
b. one member is knowledgeable in ethics;
c. one member is knowledgeable in the relevant law. That member should not be the institution’s legal counsel or risk manager. This is mandatory for biomedical research and is advisable, but not mandatory, for other areas of research; and
d. one community member has no affiliation with the institution. (Canadian Institutes of Health Research et al., 2022, Article 6.4, p. 97).
Additionally, Health Canada requires that “a majority of [REB members] are Canadian citizens or permanent residents” (Government of Canada, 1985, C.03.306). The majority of Canada’s universities and health care delivery organizations (hospitals, health networks/authorities) have, or are affiliated with, local REBs. In some cases, researchers use a centralized REB (e.g., Ontario Cancer Research Ethics Board), a harmonized process (e.g., Research Ethics BC), an independent REB, or a single ethics process across research and practice activities inclusive of research, quality improvement (QI), program evaluation, etc. (e.g., Public Health Ontario). As noted above, REBs follow the guidelines of the TCPs 2, as well as other relevant ethical guidelines, policies, legislation, and regulation that apply depending on the research project. In addition, REBs and communities have collaborated to develop specific guidelines and enact their own processes for research ethical review that are sensitive to types of research or local communities. Examples of community-led ethical guidelines are increasingly available in relation to research involving Indigenous peoples (Hayward et al., 2021). Examples of such guidelines include the National Inuit Strategy on Research (Inuit Tapiriit Kanatami, 2018), as well as research involving communities marginalized by society, such as Vancouver’s Downtown Eastside (Neufeld et al., 2019).
The Four Main Roles That Nurses Have Related to Research Ethics
The TCPs 2’s core principles—respect for persons, concern for welfare, and justice—align well with the seven primary values in the CNA Code of Ethics for Registered Nurses (2017):
• providing safe, compassionate, competent and ethical care
• promoting health and well-being
• promoting and respecting informed decision-making
• honouring dignity
• maintaining privacy and confidentiality
• promoting justice
• being accountable (pp. 8–16)
Nurses are often at the point of care and are important advocates for patients and families, and so frequently find themselves at the front lines of health care research. Consequently, nurses across the profession need a good working knowledge of how ethical principles apply in the research context, how research ethics processes work, and how to identify and respond to ethical issues in research. In this section, we use Ethics in Practice case studies to explore the four main roles that nurses have related to research and some of the ethical issues that can arise: (1) as care providers (2) as managers and leaders (3) as researchers and research coordinators, and (4) as serving REB members. We give examples of how the core ethical principles and primary nursing values can be put into practice. Parts of this section were adapted from Chapter 14, written by Oberle & Storch (2013), in the second edition of Toward a Moral Horizon: Nursing Ethics for Leadership and Practice (Storch et al., 2013) and the CNA Ethical Research Guidelines for Registered Nurses (2002).
1. Nurses as Care Providers
Nurses working in organizations, and across all levels of practice, may be involved in a variety of activities, including research, quality improvement (QI), and program evaluation, to improve care and services (Faden et al., 2013). Nurses may be direct care providers for patients (clients, residents) and families, and may, at times, be research participants themselves, or researchers. The obligations of the nurse in these diverse roles may present ethical challenges. The practice/research distinction that began with the Belmont Report is founded on the belief that in clinical practice, patients’ immediate interests are addressed because health care professionals are obligated to care for individual patients in a way that is personalized to benefit each patient via standard care. On the other hand, in research activities, study participants are subjected to potential risks of harm for the benefit of future patients, the larger population, and/or to further the researchers’ or institutions’ goals. At times, the boundary between clinical care and clinical research is blurred, such as in cancer care (Kass et al., 2013). Likewise, boundaries between health care improvement/evaluation and research activities can also be unclear.
With regards to the harmony between research and practice, nurses require an understanding of such things as: what research is going on in their area; if patients (or their legal health care representatives) understand the nature of the studies they have voluntarily consented to participate in; if they (as nurses) are required to carry out research procedures; and how research project requirements fit into their other nursing responsibilities. If nurses find any elements of the research conducted in their workplaces troubling, these concerns should be voiced to researchers, nursing managers, or the REB. Each nurse is accountable for their own practice. This is not to suggest that it is easy—speaking up requires considerable moral courage and excellent communication skills.
2. Nurses as Managers and Leaders
Nurses may be managers and leaders in organizations where there is an ongoing range of learning activities including research, QI, and program evaluation to improve care and services. Frontline nurse managers and leaders are responsible for assessing and managing nursing workload and quality of care, ensuring a positive work environment, fostering a moral climate, and managing unit budgets.
Research activities can have an impact on all of these areas, and in many institutions, operational approval by nurse managers or leaders is required before a researcher is permitted to bring a study into the organization. Before providing that signature, the manager has a responsibility to become familiar with the protocol, ask any questions that arise, and await satisfactory answers provided by the researcher. If there is no operational approval requirement for research within an institution, managers should be prepared to seek a change in organizational policy. Part of that policy should include an outline of responsibilities of nurse managers and staff nurses in regard to research activities; statements about workload and funding issues; and requirements for nursing support, including education. Organizations should not be silent on such matters, as failure to address such issues can place patients, their families, and nurses at unnecessary risk and cause undue stress.
3. Nurses as Researchers and Research Coordinators
Advanced Practice Nurses (APNs) may be principal investigators or co-investigators in their own studies, and nurses at all levels of practice may work as research assistants or research coordinators for other health care research studies. REBs generally provide research teams with comprehensive procedural guidance and direction on determining, first of all, if a research project requires REB review (TCPs 2 guidance on Scope of Research Ethics Review). Such guidance is helpful to research teams preparing a submission to the REB. The research protocol, the document that describes the overall planning of a study, is a critical component of an REB application. Research protocols generally include a comprehensive description of each of the following elements:
•background and rationale
• objectives
• methods
• recruitment of human participants
• informed consent/assent
• potential harms and benefits to participants, families, and communities
• privacy and confidentiality
• knowledge translation and dissemination plan
• budget, potential biases and limitations
• other considerations where relevant (e.g., multijurisdictional research; sex and gender)
Appendix 2-1 summarizes the key considerations when writing research proposals. Individual REBs typically provide guidance on what information should be covered in each section of a research protocol. For example, Health Canada’s REB (Health Canada, 2022) provides a helpful summary of key considerations. We advise applicants preparing an REB submission to follow the directions carefully to ensure their research protocols provide sufficient ethical and methodological detail so that the REB can assess the proposal. The protocol must be written in order that each REB member (even those members who are not experts in the field of the research) will be able to understand the research.
A complete research submission includes related documents such as questionnaires, interview scripts, recruitment materials, and consent and assent forms. Informed consent for research also involves processes that need to be established for the research to begin. Key areas to be included in an informed consent discussion include: (a) protection of confidentiality (b) knowledge of the processes involved (c) understanding about any discomforts and inconveniences, foreseeable risks and costs, and (d) any benefits and compensation provided (Kluge, 2013). Some REBs provide checklist tools to help identify required regulations, guidelines, and policies to ensure all applicable elements are present in the study documents. At times, the REB requests that the researcher (or principal investigator) present to the REB or answer questions. A research project cannot begin until the REB has given full unconditional approval. However, in some areas of research, and particularly the qualitative paradigm, the process of gaining entry (the ethical and academic processes the researcher undertakes to access and engage with research participants and the broader professional and institutional community) can blur the lines of when research data is collected. The TCPS 2 chapter on Qualitative Research is helpful in this regard.
Once a research project is approved and underway, reflexivity is an integral part of the process of rigorous inquiry that involves researchers being able to be critically reflective of the research process they are engaged in. As noted by Australian ethicists Marilys Guillemin and Lynn Gillam (2004),
Being reflexive about research practice means a number of things: first, an acknowledgment of micro-ethics, that is, of the ethical dimensions of ordinary, everyday research practice; second, sensitivity to what we call the “ethically important moments” in research practice, in all their particularities; and third, having or being able to develop a means of addressing and responding to ethical concerns if and when they arise in the research (which might well include a way of preempting potential ethical problems before they take hold). (p. 276)
4. Nurses as REB Members
Finally, APNs may be members of REBs. Serving on an REB is an important role for advanced practice nurses to consider, both to learn more about the work of assessing research in line with the TCPS 2 and to add safeguards of local significance. Both authors of this chapter have served on REBs and consulted with REBs. We have found REB service to be a good way to learn and keep abreast of the TCPS 2 guidelines while also developing knowledge in new areas of practice and research. Because APNs serving on an REB have a breadth of experience in nursing practice, they are normally the first to pick up on research measures that would be difficult or contraindicated for patients/families or other potential participants (such as staff). Nurses are also often more sensitive to the patient and family experience of the research.
Research involving humans can be ethically justified only when the research is scientifically sound, the potential benefit significantly outweighs the potential for harm, there is an adequate process for informed consent (assent where applicable), and there is justice or fairness in the selection of participants. For example, Health Canada’s REB (2022) provides a useful summary of key considerations when reviewing research proposals to assess whether a proposal meets the ethical requirements for research involving humans, including
•methodology (e.g., if the study is likely to produce valid results)
• selection and recruitment (e.g., based on sex, gender, age, ethnicity, and language)
• informed consent process (e.g., voluntariness, capacity, and comprehension)
• potential harms and benefits, and how these are distributed
• privacy and confidentiality (e.g., highly sensitive information, identifying information, biological samples), and
• any real, apparent, or potential conflicts of interest that may affect how the research is conducted
An ill-designed study is a waste of resources (time, funding dollars, personnel) and possibly participants’ goodwill—and is therefore unethical. Appendix 2-1 summarizes the key considerations when reviewing research proposals.
Research Ethics on the Moral Horizon: Vigilance Must Be Ongoing
In this chapter, we have reviewed key events in the recent era of Euro-Western research ethics. We have outlined respect for persons, concern for welfare, and justice, as the core principles of the TCPS 2. We have discussed the role and function of research ethics boards in Canada and provided examples of how the TCPS 2, Canada’s standard for ethical research, works in conjunction with other codes, legislation, and guidelines. In addition, we have identified four key roles for advanced practice nurses in promoting ethical research and provided examples of ethical issues that can arise in each of these areas.
Nurses must be vigilant when it comes to research ethics. Unfortunately, despite more than half a century’s evolution of bioethics and research ethics oversight, it is clear that health care ethics-related transgressions are not a thing of the past. At this time, we have noted three violations of health care ethics and human rights recently reported:
•Lipphardt et al. (2021) identified concerns with how researchers analyzed the genetic data of marginalized populations via public DNA databases, focusing on implications for Roma people.
• Taylor (2021) raised issues about an experimental COVID-19 “cure” tested in Brazil in 2021.
• In April 2022, Health Canada announced a review of all trials involving methylenedioxymethamphetamine (MDMA, also known as “ecstasy”) to ensure patient safety and compliance with regulations (Lindsay, 2022).
As information is uncovered—and as societal attitudes, norms and ethical awareness evolve—new accounts of abuse of research participants and scientific misconduct (such as data falsification, data fabrication, or plagiarism [Marcus & Oransky, n.d.]) continue to be revealed (Emanuel et al., 2008; Pimple, 2017; Resnick, 2018). For these reasons, we urge nurses to advocate for the appropriate representation of, and collaboration with, diverse and historically underserved populations in research, and to consider the perspectives of research participants. In this chapter, we have underscored the active and critical roles that those in the nursing profession—and particularly advanced practice nurses—play in protecting the rights and welfare of patients and research participants while advancing the pursuit of knowledge.
1. What kinds of guidelines are in place in your workplace to guide nurses’ involvement in research?
2. Why might there be gaps between what you think nurses ought to do in research-related situations, what nurses believe they ought to do, and what nurses actually do?
2. What kinds of research-related issues have you encountered in your practice, and what action have you taken?
2. What kinds of opportunities do advanced practice nurse leaders have to promote ethical research in ways that:
• uphold the primary values in the nursing profession?
• increase collaboration with diverse and historically underserved populations?
• better align with diverse community values/needs and broader societal goals, such as Indigenous reconciliation and social justice?
Endnotes
1 In this chapter, we draw on content from: Oberle, K., & Storch, J. L. (2013). Research ethics in nursing. In J. L. Storch, P. Rodney, & R. Starzomski (Eds.), Toward a moral horizon: Nursing ethics for leadership and practice (2nd ed., pp. 282–301). Pearson.
References
Alberta Innovates. (2017). ARECCI ethics screening tool. https://arecci.albertainnovates.ca
Anderson, J. A., Sawatzky-Girling, B., McDonald, M., & Willison, D. J. (2011). Research ethics broadly writ: Beyond research ethics review. Health Law Review, 19(3), 12–24.
Arbour, L., & Cook, D. (2006). DNA on loan: Issues to consider when carrying out genetic research with aboriginal families and communities. Community Genetics, 9(3), 153.
Associated Press. (2021, October 4). Henrietta Lacks’s estate sues biotech firm over “stolen” immortal cancer cells. CBC News. https://www.cbc.ca/news/science/henrietta-lacks-lawsuit-1.6198926
Bartlett, C., Marshall, M., & Marshall, A. (2012). Two-Eyed Seeing and other lessons learned within a co-learning journey of bringing together indigenous and mainstream knowledges and ways of knowing. Journal of Environmental Studies and Sciences, 2(4), 331–340. https://doi.org/10.1007/s13412-012-0086-8
Baylis, F., Hoffmaster, B., Sherwin, S. B., & Borgerson, K. (2012). Health care ethics in Canada (3rd ed.). Nelson Education.
Beauchamp, T. L., & Childress, J. F. (2019). Principles of biomedical ethics (8th ed.). Oxford University Press.
Beecher, H. (1966). Ethics and clinical research. The New England Journal of Medicine, 274(24), 1354–1360.
Bull, J. (2016). A Two-Eyed Seeing approach to research ethics review: An Indigenous perspective. In W. C. van den Hoonaard & A. Hamilton (Eds.), The ethics rupture (pp. 167–186). University of Toronto Press. https://doi.org/10.3138/9781442616653-012
Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, & Social Sciences and Humanities Research Council of Canada. (2022). Tri-council policy statement: Ethical conduct for research involving humans—TCPS 2 2022. https://ethics.gc.ca/eng/policy-politique_tcps2-eptc2_2022.html
Canadian Nurses Association. (1994). Ethical research guidelines for nurses in research involving human participants (2nd revised edition). Canadian Nurses Association.
Canadian Nurses Association. (2002). Ethical research guidelines for registered nurses.
Canadian Nurses Association. (2017). Code of ethics for registered nurses. https://www.cna-aiic.ca/en/nursing/regulated-nursing-in-canada/nursing-ethics
Cashore, H., & Smart, V. (Directors). (2017, December 15). Brainwashed: The secret CIA experiments in Canada. Canadian Broadcasting Corporation. https://gem.cbc.ca/media/the-fifth-estate/s43e13?cmp=sch-brainwashed
Collins, A. (1997). In the sleep room: The story of the CIA brainwashing experiments in Canada. Key Porter Books.
Copeland, D. (2021). Nurses’ participation in the Holocaust: A call to nursing educators. Journal of Professional Nursing: Official Journal of the American Association of Colleges of Nursing, 37(2), 426–428. https://doi.org/10.1016/j.profnurs.2020.05.003
Dunn, C. M., & Chadwick, G. (2004). Protecting study volunteers in research: A manual for investigative sites. CenterWatch.
Emanuel, E. J., Grady, C., Crouch, R. A., Lie, R. K., Miller, F. G., & Wendler, D. (Eds.). (2008). The Oxford textbook of clinical research ethics. Oxford University Press.
Faden, R. R., Kass, N. E., Goodman, S. N., Pronovost, P. J., Tunis, S., & Beauchamp, T. L. (2013). An ethics framework for a learning health care system: A departure from traditional research ethics and clinical ethics. The Hastings Center Report, 43(s1), S16–27. https://doi.org/10.1002/hast.134
First Nations Information Governance Centre. (n.d.). The First Nations Principles of OCAP®. Retrieved March 1, 2022, from https://fnigc.ca/ocap-training/
Gilmore, N., Somerville, M., & Negrete, J.-C. (1998). A review of the use of LSD and ECT at the Prison for Women in the early 1960’s. Correctional Service Canada.
Government of BC. (1996). Health Care (Consent) and Care Facility (Admission) Act (RSBC 1996, c 181). https://canlii.ca/t/520ts
Government of BC. (2003). Personal Information Protection Act (SBC 2003, c 63). http://canlii.ca/t/jjk2
Government of Canada. (1985). Food and Drugs Act (RSC 1985, c F-27). https://laws-lois.justice.gc.ca/eng/acts/f-27/index.html
Government of Canada. (2000). Personal Information Protection and Electronic Documents Act (SC 2000, c 5). https://canlii.ca/t/7vwj
Guillemin, M., & Gillam, L. (2004). Ethics, reflexivity, and “ethically important moments” in research. Qualitative Inquiry, 10, 261–280. https://doi.org/10.1177/1077800403262360
Halpern, S. (2004). Lesser harms: The morality of risk in medical research. University of Chicago Press.
Harvard Law School Library. (2020, March). Nuremberg Military Tribunal Case 1: U.S.A. v. Karl Brandt et al.: The Doctors’ Trial. HLS Nuremberg Trials Project. https://nuremberg.law.harvard.edu/nmt_1_intro
Ha-Shilth-Sa. (2013, July 22). Blood taken for research destroyed. Ha-Shilth-Sa. https://hashilthsa.com/news/2013-07-22/blood-taken-research-destroyed
Hayward, A., Sjoblom, E., Sinclair, S., & Cidro, J. (2021). A new era of Indigenous research: Community-based Indigenous research ethics protocols in Canada. Journal of Empirical Research on Human Research Ethics, 16(4), 403–417. https://doi.org/10.1177/15562646211023705
Health Canada. (2022, October 27). Research protocol instructions. Government of Canada. https://www.canada.ca/en/health-canada/services/science-research/science-advice-decision-making/research-ethics-board/apply-ethics-review.html#a4
Heller, J. (1972, July 26). Syphilis victims in U.S. study went untreated for 40 years. New York Times. https://www.nytimes.com/1972/07/26/archives/syphilis-victims-in-us-study-went-untreated-for-40-years-syphilis.html
International Conference on Harmonisation. (n.d.). Guideline for Good Clinical Practice. Retrieved March 1, 2022, from https://ichgcp.net
Inuit Tapiriit Kanatami. (2018). National Inuit strategy on research. https://www.itk.ca/national-inuit-strategy-on-research/
Jones, J. H. (2008). The Tuskegee syphilis experiment. In E. J. Emanuel, C. Grady, R. A. Crouch, R. K. Lie, F. G. Miller, & D. Wendler (Eds.), The Oxford textbook of clinical research ethics (pp. 86–96). Oxford University Press.
Juskewitch, J. E., Tapia, C. J., & Windebank, A. J. (2010). Lessons from the Salk polio vaccine: Methods for and risks of rapid translation. Clinical and Translational Science, 3(4), 182–185. https://doi.org/10.1111/j.1752-8062.2010.00205.x
Kara, H. (2018). Research ethics in the real world: Euro-Western and Indigenous perspectives. Policy Press.
Kass, N. E., Faden, R. R., Goodman, S. N., Pronovost, P. J., Tunis, S., & Beauchamp, T. L. (2013). The research-treatment distinction: A problematic approach for determining which activities should have ethical oversight. The Hastings Center Report, 43(s1), S4–S15. https://doi.org/10.1002/hast.133
Kluge, E.-H. W. (2013). Ethics in health care: A Canadian focus (1st ed.). Pearson Canada.
Lederer, S. E. (1995). Subjected to science: Human experimentation in America before the Second World War. Johns Hopkins University Press.
Lemov, R. (2011). Brainwashing’s avatar: The curious career of Dr. Ewen Cameron. Grey Room, 45, 61–87.
Lindsay, B. (2022, April 8). Health Canada announces review of all MDMA trials, as complaint alleges major flaws and safety issues. CBC News. https://www.cbc.ca/news/canada/british-columbia/health-canada-mdma-trial-complaints-flaws-safety-issues-1.6409849
Lipphardt, V., Surdu, M., Ellebrecht, N., Pfaffelhuber, P., Wienroth, M., & Rappold, G. A. (2021). Europe’s Roma people are vulnerable to poor practice in genetics. Nature, 599(7885), 368–371. https://doi.org/10.1038/d41586-021-03416-3
Luna, F., & Macklin, R. (2009). Research involving human beings. In H. Kuhse & P. Singer (Eds.), A companion to bioethics (2nd ed.). Wiley.
MacDonald, N. E., Stanwick, R., & Lynk, A. (2014). Canada’s shameful history of nutrition research on residential school children: The need for strong medical ethics in Aboriginal health research. Paediatrics & Child Health, 19(2), 64–64. https://doi.org/10.1093/pch/19.2.64
McDonald, M. (2000). The governance of health research involving human subjects (HRIHS). Law Commission of Canada. http://www.publications.gc.ca/site/eng/325188/publication.html
Meldrum, M. L. (2008). The Salk polio vaccine trial of 1954. In E. J. Emanuel, C. Grady, R. A. Crouch, R. K. Lie, F. G. Miller, & D. Wendler (Eds.), The Oxford textbook of clinical research ethics (pp. 61–72). Oxford University Press.
Mosby, I. (2013). Administering colonial science: Nutrition research and human biomedical experimentation in Aboriginal communities and residential schools, 1942-1952. Social History, 46(91), 145–172.
Mozes Kor, E., & Wright, M. (1995). Echoes from Auschwitz: Dr. Mengele’s twins; the story of Eva and Miriam Mozes. Candles.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont report: Ethical principles and guidelines for the protection of human subjects of research. U.S. Department of Health, Education, and Welfare. http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html
Neufeld, S. D., Chapman, J., Crier, N., Marsh, S., McLeod, J., & Deane, L. A. (2019). Research 101: A process for developing local guidelines for ethical research in heavily researched communities. Harm Reduction Journal, 16(1), 41. https://doi.org/10.1186/s12954-019-0315-5
Nuremberg Code. (1949). Trials of war criminals before the Nuremberg military tribunals under Control Council Law No. 10 (Vol. 2; pp. 181–182). U.S. Government Printing Office. https://history.nih.gov/display/history/Nuremberg+Code
Nuu-chah-nulth Tribal Council Research Ethics Committee. (2008). Protocols and principles for conducting research in a Nuu-chah-nulth context. https://icwrn.uvic.ca/wp-content/uploads/2013/08/NTC-Protocols-and-Principles.pdf
Oberle, K., & Storch, J. L. (2013). Research ethics and nursing. In J. L. Storch, P. Rodney, & R. Starzomski (Eds.), Toward a moral horizon: Nursing ethics for leadership and practice (2nd ed., pp. 282–301). Pearson Canada.
Panel on Research Ethics. (2023a). Home Page. Government of Canada. https://ethics.gc.ca/eng/home.html
Panel on Research Ethics. (2023b). TCPS 2: CORE-2022 (Course on Research Ethics). Government of Canada. http://tcps2core.ca/welcome
Pimple, K. D. (Ed.). (2017). Research ethics. Ashgate Publishing, Ltd.
Resnick, D. B. (2018). The ethics of research with human subjects: Protecting people, advancing science, promoting trust. Springer International Publishing.
Robinson, W. M., & Unruh, B. T. (2008). The hepatitis experiments at the Willowbrook State School. In E. J. Emanuel, C. Grady, R. A. Crouch, R. K. Lie, F. G. Miller, & D. Wendler (Eds.), The Oxford textbook of clinical research ethics (pp. 80–85). Oxford University Press.
Seidelman, W. E. (1988). Mengele medicus: Medicine’s Nazi heritage. The Milbank Quarterly, 66(2), 221–239.
Shields, L., & Benedict, S. (Eds.). (2014). Nurses and midwives in Nazi Germany. Routledge.
Skloot, R. (2010). The immortal life of Henrietta Lacks. Macmillan.
Stark, L. (2011). Behind closed doors: IRBs and the making of ethical research. University of Chicago Press.
Storch, J. L., Rodney, P., & Starzomski, R. (Eds.). (2013). Toward a moral horizon: Nursing ethics for leadership and practice (2nd ed.). Pearson.
Taylor, L. (2021). Covid-19: Trial of experimental “covid cure” is among worst medical ethics violations in Brazil’s history, says regulator. British Medical Journal, n2819. https://doi.org/10.1136/bmj.n2819
Tennant, Z. (Director). (2021, April 19). The dark history of Canada’s Food Guide: How experiments on Indigenous children shaped nutrition policy. In Unreserved. Canadian Broadcasting Corporation. https://www.cbc.ca/radio/unreserved/how-food-in-canada-is-tied-to-land-language-community-and-colonization-1.5989764/the-dark-history-of-canada-s-food-guide-how-experiments-on-indigenous-children-shaped-nutrition-policy-1.5989785
Truth and Reconciliation Commission of Canada. (2015). Final report of the Truth and Reconciliation Commission of Canada. James Lorimer & Company. https://nctr.ca/records/reports/
Tsuchiya, T. (2008). The Imperial Japanese experiments in China. In E. J. Emanuel, C. Grady, R. A. Crouch, R. K. Lie, F. G. Miller, & D. Wendler (Eds.), The Oxford textbook of clinical research ethics (pp. 31–45). Oxford University Press.
Veatch, R. M. (1977). Case studies in medical ethics. Harvard University Press.
Weindling, P. J. (2008). The Nazi medical experiments. In E. J. Emanuel, C. Grady, R. A. Crouch, R. K. Lie, F. G. Miller, & D. Wendler (Eds.), The Oxford textbook of clinical research ethics (pp. 18–30). Oxford University Press.
Wilson, S. (2008). Research is ceremony: Indigenous research methods. Fernwood Publishing.
Wiwchar, D. (2004, December 16). Nuu-Chah-Nulth blood returns to West Coast. Ha-Shilth-Sa Newspaper. https://issuu.com/hashilthsa/docs/25_december_16__2004
World Medical Association. (1964). Declaration of Helsinki: Recommendations guiding doctors in clinical research (18th WMA General Assembly, Helsinki, Finland). https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
We use cookies to analyze our traffic. Please decide if you are willing to accept cookies from our website. You can change this setting anytime in Privacy Settings.